This latter observation is consistent with our recent publication in which we demonstrated that systemic RelB expression was associated with health outcomes during acute exacerbations in COPD but was not associated with clinical features during stable-state [55]. This evidence concerns the gene RELB and chronic obstructive pulmonary disease.